Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2015473

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2015473

Peripheral Stent Implants Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 192 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global peripheral stent implants market is experiencing notable expansion as the burden of peripheral artery diseases continues to rise worldwide. Peripheral stents are essential medical devices used to treat narrowed or blocked arteries outside the coronary region, particularly in the lower limbs and carotid arteries. With the growing adoption of minimally invasive procedures and increasing awareness of vascular health, the demand for peripheral stent implants is gaining strong momentum. Advancements in interventional techniques and device design are further contributing to improved patient outcomes, positioning the market for sustained growth.

Market Insights

The peripheral stent implants market is projected to reach USD 4.2 billion in 2026 and is expected to grow to USD 6.4 billion by 2033, registering a compound annual growth rate (CAGR) of 6.20% during the forecast period. This steady growth reflects the increasing incidence of peripheral artery disease (PAD), particularly among aging populations and individuals with chronic health conditions such as diabetes and hypertension. Continuous innovation in stent technologies, including drug-eluting and covered stents, is also supporting market expansion by enhancing procedural success rates and reducing complications.

Market Drivers

A major factor driving the market is the rising prevalence of lifestyle-related diseases that contribute to vascular complications. Sedentary lifestyles, poor dietary habits, and increasing tobacco use are significantly elevating the risk of arterial blockages, thereby increasing the need for effective treatment solutions such as stent implantation.

Technological advancements in stent design and materials are also playing a crucial role in market growth. Drug-eluting stents, which release therapeutic agents to prevent restenosis, are gaining widespread acceptance due to their improved clinical outcomes. Additionally, the development of flexible and durable stents allows physicians to treat complex lesions more effectively.

The growing preference for minimally invasive procedures is another key driver. Compared to traditional surgical methods, stent-based interventions offer reduced recovery times, lower risk of complications, and shorter hospital stays. This shift in treatment preference is encouraging healthcare providers to adopt advanced stenting solutions.

Business Opportunities

The peripheral stent implants market presents significant opportunities for industry participants. Emerging economies are becoming key growth hubs due to increasing healthcare investments, improving infrastructure, and rising patient awareness. Countries across Asia Pacific and Latin America are witnessing higher adoption rates of advanced medical technologies, creating new avenues for market expansion.

Innovation remains a critical area of opportunity. Companies investing in next-generation stents with enhanced biocompatibility, better drug delivery systems, and improved structural integrity are likely to gain a competitive advantage. Furthermore, the integration of imaging technologies with stenting procedures is expected to enhance precision and treatment outcomes.

Strategic initiatives such as partnerships, mergers, and acquisitions are also shaping the competitive landscape. Leading players are focusing on expanding their global footprint and strengthening their product portfolios to address diverse clinical needs.

Regional Analysis

North America continues to dominate the peripheral stent implants market, supported by a high prevalence of vascular diseases, well-established healthcare systems, and rapid adoption of advanced technologies. The presence of major market players and favorable reimbursement frameworks further strengthens the region's position.

Europe holds a substantial share of the market, driven by increasing healthcare awareness and a growing elderly population. The region is characterized by steady adoption of innovative medical devices and supportive healthcare policies.

Asia Pacific is anticipated to register the fastest growth over the forecast period. Factors such as rising healthcare expenditure, large patient populations, and improving access to medical services are fueling demand in countries like India and China. Government initiatives aimed at enhancing healthcare infrastructure are also contributing to regional growth.

Latin America and the Middle East and Africa are gradually emerging as potential markets. Improvements in healthcare delivery systems and increasing focus on early diagnosis and treatment are expected to support market development in these regions.

Key Players

  • Abbott Laboratories
  • Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Cook Medical, Inc.
  • Boston Scientific Corporation
  • iVascular SLU
  • Cardinal Health, Inc.
  • Terumo Corporation
  • Medtronic Plc.
  • L. Gore & Associates, Inc.
  • R. Bard, Inc.
  • MicroPort Scientific Corporation

The peripheral stent implants market is set to witness consistent growth, driven by the increasing prevalence of vascular disorders and continuous advancements in medical technology. As healthcare providers increasingly adopt minimally invasive approaches, the demand for efficient and reliable stent solutions is expected to rise. Companies that prioritize innovation, strategic expansion, and quality enhancement will be well-positioned to capitalize on the evolving market landscape.

Market Segmentation

By Product

  • Bare Metal Stents (BMS)
  • Covered Stents
  • Drug Eluting Stents (DES)

By Artery

  • Carotid Artery Stents
  • Fem-Pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

By End User

  • Hospitals
  • Ambulatory Surgical Centers/Outpatient

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Peripheral Stent Implants Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Peripheral Stent Implants Market Outlook, 2020-2033

  • 3.1. Global Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Bare Metal Stents (BMS)
    • 3.1.2. Covered Stents
    • 3.1.3. Drug Eluting Stents (DES)
  • 3.2. Global Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 3.2.1. Carotid Artery Stents
    • 3.2.2. Fem-Pop Artery Stents
    • 3.2.3. Iliac Artery Stents
    • 3.2.4. Infrapop Artery Stents
  • 3.3. Global Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Ambulatory Surgical Centers/Outpatient
  • 3.4. Global Peripheral Stent Implants Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Peripheral Stent Implants Market Outlook, 2020-2033

  • 4.1. North America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Bare Metal Stents (BMS)
    • 4.1.2. Covered Stents
    • 4.1.3. Drug Eluting Stents (DES)
  • 4.2. North America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 4.2.1. Carotid Artery Stents
    • 4.2.2. Fem-Pop Artery Stents
    • 4.2.3. Iliac Artery Stents
    • 4.2.4. Infrapop Artery Stents
  • 4.3. North America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers/Outpatient
  • 4.4. North America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 4.4.3. U.S. Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 4.4.6. Canada Peripheral Stent Implants Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Peripheral Stent Implants Market Outlook, 2020-2033

  • 5.1. Europe Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Bare Metal Stents (BMS)
    • 5.1.2. Covered Stents
    • 5.1.3. Drug Eluting Stents (DES)
  • 5.2. Europe Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 5.2.1. Carotid Artery Stents
    • 5.2.2. Fem-Pop Artery Stents
    • 5.2.3. Iliac Artery Stents
    • 5.2.4. Infrapop Artery Stents
  • 5.3. Europe Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Ambulatory Surgical Centers/Outpatient
  • 5.4. Europe Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.3. Germany Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.6. Italy Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.7. France Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.8. France Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.9. France Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.12. U.K. Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.15. Spain Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.18. Russia Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 5.4.21. Rest of Europe Peripheral Stent Implants Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peripheral Stent Implants Market Outlook, 2020-2033

  • 6.1. Asia Pacific Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Bare Metal Stents (BMS)
    • 6.1.2. Covered Stents
    • 6.1.3. Drug Eluting Stents (DES)
  • 6.2. Asia Pacific Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 6.2.1. Carotid Artery Stents
    • 6.2.2. Fem-Pop Artery Stents
    • 6.2.3. Iliac Artery Stents
    • 6.2.4. Infrapop Artery Stents
  • 6.3. Asia Pacific Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers/Outpatient
  • 6.4. Asia Pacific Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.2. China Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.3. China Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.6. Japan Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.9. South Korea Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 6.4.10. India Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.11. India Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.12. India Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.15. Southeast Asia Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 6.4.18. Rest of SAO Peripheral Stent Implants Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peripheral Stent Implants Market Outlook, 2020-2033

  • 7.1. Latin America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Bare Metal Stents (BMS)
    • 7.1.2. Covered Stents
    • 7.1.3. Drug Eluting Stents (DES)
  • 7.2. Latin America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 7.2.1. Carotid Artery Stents
    • 7.2.2. Fem-Pop Artery Stents
    • 7.2.3. Iliac Artery Stents
    • 7.2.4. Infrapop Artery Stents
  • 7.3. Latin America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers/Outpatient
  • 7.4. Latin America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 7.4.3. Brazil Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 7.4.6. Mexico Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 7.4.9. Argentina Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 7.4.12. Rest of LATAM Peripheral Stent Implants Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peripheral Stent Implants Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Bare Metal Stents (BMS)
    • 8.1.2. Covered Stents
    • 8.1.3. Drug Eluting Stents (DES)
  • 8.2. Middle East & Africa Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
    • 8.2.1. Carotid Artery Stents
    • 8.2.2. Fem-Pop Artery Stents
    • 8.2.3. Iliac Artery Stents
    • 8.2.4. Infrapop Artery Stents
  • 8.3. Middle East & Africa Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers/Outpatient
  • 8.4. Middle East & Africa Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 8.4.3. GCC Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 8.4.6. South Africa Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 8.4.9. Egypt Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 8.4.12. Nigeria Peripheral Stent Implants Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Peripheral Stent Implants Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
    • 8.4.15. Rest of Middle East Peripheral Stent Implants Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Braun Melsungen AG
    • 9.4.3. Biotronik SE & Co. KG
    • 9.4.4. Cook Medical, Inc.
    • 9.4.5. Boston Scientific Corporation
    • 9.4.6. iVascular SLU
    • 9.4.7. Cardinal Health, Inc.
    • 9.4.8. Terumo Corporation
    • 9.4.9. Medtronic Plc.
    • 9.4.10. L. Gore & Associates, Inc.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!